Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis - PubMed (original) (raw)
Review
Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis
P S George et al. Diabet Med. 2012 Aug.
Abstract
Aims: To systematically review the evidence for the effect of vitamin D supplementation on glycaemia, insulin resistance, progression to diabetes and complications of diabetes.
Methods: Systematic review and meta-analysis. We searched databases including MEDLINE, EMBASE and the Cochrane Library for randomized controlled trials comparing vitamin D or analogues with placebo. We extracted data on fasting glucose, glycaemic control, insulin resistance, insulin/C-peptide levels, micro- and macrovascular outcomes and progression from non-diabetes to diabetes. Studies were assessed independently by two reviewers according to a pre-specified protocol.
Results: Fifteen trials were included in the systematic review. Trial reporting was of moderate, variable quality. Combining all studies, no significant improvement was seen in fasting glucose, HbA(1c) or insulin resistance in those treated with vitamin D compared with placebo. For patients with diabetes or impaired glucose tolerance, meta-analysis showed a small effect on fasting glucose (-0.32 mmol/l, 95%CI -0.57 to -0.07) and a small improvement in insulin resistance (standard mean difference -0.25, 95%CI -0.48 to -0.03). No effect was seen on glycated haemoglobin in patients with diabetes and no differences were seen for any outcome in patients with normal fasting glucose. Insufficient data were available to draw conclusions regarding micro- or macrovascular events; two trials failed to show a reduction in new cases of diabetes in patients treated with vitamin D.
Conclusions: There is currently insufficient evidence of beneficial effect to recommend vitamin D supplementation as a means of improving glycaemia or insulin resistance in patients with diabetes, normal fasting glucose or impaired glucose tolerance.
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Similar articles
- Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.
Moreira-Lucas TS, Duncan AM, Rabasa-Lhoret R, Vieth R, Gibbs AL, Badawi A, Wolever TM. Moreira-Lucas TS, et al. Diabetes Obes Metab. 2017 Jan;19(1):133-141. doi: 10.1111/dom.12794. Epub 2016 Nov 9. Diabetes Obes Metab. 2017. PMID: 27717236 Clinical Trial. - Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis.
Poolsup N, Suksomboon N, Plordplong N. Poolsup N, et al. Diabet Med. 2016 Mar;33(3):290-9. doi: 10.1111/dme.12893. Epub 2015 Oct 6. Diabet Med. 2016. PMID: 26308752 Review. - The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis.
Li X, Liu Y, Zheng Y, Wang P, Zhang Y. Li X, et al. Nutrients. 2018 Mar 19;10(3):375. doi: 10.3390/nu10030375. Nutrients. 2018. PMID: 29562681 Free PMC article. Review. - A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans.
Harris SS, Pittas AG, Palermo NJ. Harris SS, et al. Diabetes Obes Metab. 2012 Sep;14(9):789-94. doi: 10.1111/j.1463-1326.2012.01605.x. Epub 2012 May 8. Diabetes Obes Metab. 2012. PMID: 22486948 Clinical Trial. - Effect of oral vitamin D supplementation on glycemic control in patients with type 2 diabetes mellitus with coexisting hypovitaminosis D: A parellel group placebo controlled randomized controlled pilot study.
Upreti V, Maitri V, Dhull P, Handa A, Prakash MS, Behl A. Upreti V, et al. Diabetes Metab Syndr. 2018 Jul;12(4):509-512. doi: 10.1016/j.dsx.2018.03.008. Epub 2018 Mar 16. Diabetes Metab Syndr. 2018. PMID: 29580871 Clinical Trial.
Cited by
- The Effect of Vitamin D Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Clinical Trials.
Afraie M, Bahrami P, Kohnepoushi P, Khateri S, Majidi L, Saed L, Zamani K, Baharm HM, Moradi Y, Moradpour F. Afraie M, et al. J Diabetes Res. 2024 Sep 10;2024:9960656. doi: 10.1155/2024/9960656. eCollection 2024. J Diabetes Res. 2024. PMID: 39290798 Free PMC article. - Vitamin D Deficiency as a Risk Factor for Diabetes and Poor Glycemic Control in Saudi Arabia: A Systematic Review.
Abukanna AMA, Alanazi RFA, Alruwaili FS, Alayyashi AZM, Alanzi F. Abukanna AMA, et al. Cureus. 2023 Nov 9;15(11):e48577. doi: 10.7759/cureus.48577. eCollection 2023 Nov. Cureus. 2023. PMID: 38073984 Free PMC article. Review. - Modulatory Properties of Vitamin D in Type 2 Diabetic Patients: A Focus on Inflammation and Dyslipidemia.
MacGirlley R, Phoswa WN, Mokgalaboni K. MacGirlley R, et al. Nutrients. 2023 Oct 27;15(21):4575. doi: 10.3390/nu15214575. Nutrients. 2023. PMID: 37960227 Free PMC article. Review. - 1α,25(OH)2D3 ameliorates insulin resistance by alleviating γδ T cell inflammation via enhancing fructose-1,6-bisphosphatase 1 expression.
Li P, Li K, Yuan W, Xu Y, Li P, Wu R, Han J, Yin Z, Lu L, Gao Y. Li P, et al. Theranostics. 2023 Sep 25;13(15):5290-5304. doi: 10.7150/thno.84645. eCollection 2023. Theranostics. 2023. PMID: 37908738 Free PMC article. - Vitamin D improves the antidiabetic effectiveness of aerobic training via modulation of Akt, PEPCK, and G6Pase expression.
Hoseini Z, Behpour N, Hoseini R. Hoseini Z, et al. Diabetol Metab Syndr. 2023 Sep 9;15(1):184. doi: 10.1186/s13098-023-01158-y. Diabetol Metab Syndr. 2023. PMID: 37689713 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous